Sign up to save your podcasts
Or
Share Episode 330 - Zan Fleming - Founder and Executive Chairman of Kinexum
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Episode 330 - Zan Fleming - Founder and Executive Chairman of Kinexum
In this episode of the Diabetes Innovators Series, the conversation
explores the evolution of diabetes treatment, the challenges faced in
managing diabetes today, and the future of diabetes research. Zan, an
endocrinologist and former FDA executive and Founder and executive chairman
of Kinexum, shares insights from his career, including the historical
context of diabetes management, the importance of A1C as a marker, and the
potential of new treatments like GLP-1 agonists. The discussion also
touches on the concept of meta-abesity, the shared root causes of chronic
diseases, and the need for a focus on health span rather than just
lifespan.
Chapters
00:00 Introduction to Diabetes Innovation Series
03:06 Zan's Journey in Diabetes Research
06:05 Transforming Diabetes Treatment: A Historical Perspective
09:00 The Evolution of Diabetes Management Tools
11:42 Challenges in Diabetes Management Today
14:41 The Future of Diabetes Treatment: Aiming for a Cure
17:57 Understanding the Drug Approval Process
20:32 Meta-Abesity: A New Perspective on Chronic Diseases
23:48 Innovations in Longevity and Health Span
26:27 The Role of GLP-1 Agonists in Diabetes Management
29:29 Future Directions in Diabetes Research
32:29 Memorable Moments in Drug Proposals
35:37 Conclusion and Future Collaborations
Resources:
Kinexum
Zan Fleming
View all episodes
By Diabetics Doing Things
4.6
5656 ratings
In this episode of the Diabetes Innovators Series, the conversation
explores the evolution of diabetes treatment, the challenges faced in
managing diabetes today, and the future of diabetes research. Zan, an
endocrinologist and former FDA executive and Founder and executive chairman
of Kinexum, shares insights from his career, including the historical
context of diabetes management, the importance of A1C as a marker, and the
potential of new treatments like GLP-1 agonists. The discussion also
touches on the concept of meta-abesity, the shared root causes of chronic
diseases, and the need for a focus on health span rather than just
lifespan.
Chapters
00:00 Introduction to Diabetes Innovation Series
03:06 Zan's Journey in Diabetes Research
06:05 Transforming Diabetes Treatment: A Historical Perspective
09:00 The Evolution of Diabetes Management Tools
11:42 Challenges in Diabetes Management Today
14:41 The Future of Diabetes Treatment: Aiming for a Cure
17:57 Understanding the Drug Approval Process
20:32 Meta-Abesity: A New Perspective on Chronic Diseases
23:48 Innovations in Longevity and Health Span
26:27 The Role of GLP-1 Agonists in Diabetes Management
29:29 Future Directions in Diabetes Research
32:29 Memorable Moments in Drug Proposals
35:37 Conclusion and Future Collaborations
Resources:
Kinexum
Zan Fleming
More shows like Diabetics Doing Things Podcast
View all
The Moth
27,235 Listeners
The Sporkful
3,934 Listeners
Diabetes Core Update
106 Listeners
Juicebox Podcast: Type 1 Diabetes
1,597 Listeners
Diabetes Connections | Type 1 Diabetes
217 Listeners
Christopher Kimball’s Milk Street Radio
2,953 Listeners
Ridiculous History
4,497 Listeners
Dateline NBC
47,568 Listeners
SmartLess
57,726 Listeners
IMO with Michelle Obama and Craig Robinson
12,713 Listeners
The Ezra Klein Show
15,459 Listeners
Reclaim Your Rise: Type 1 Diabetes with Lauren Bongiorno
130 Listeners
Diabetech - Diabetes Tech, Research, News
43 Listeners
The Retrievals
10,699 Listeners
Think Like A Pancreas...The Podcast!
9 Listeners